Gene T Yoshikawa1, Nicholas Simon2, Ryon K Nakasone3, Jared D Acoba4,5,6. 1. University of Hawai'i Internal Medicine Residency Program, Honolulu, HI, USA. 2. John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, USA. 3. Internal Medicine Department, University of Hawai'i, Honolulu, HI, USA. 4. Internal Medicine Department, University of Hawai'i, Honolulu, HI, USA. jacoba@hawaii.edu. 5. University of Hawai'i Cancer Center, Honolulu, HI, USA. jacoba@hawaii.edu. 6. Queen's Medical Center, Honolulu, HI, USA. jacoba@hawaii.edu.
Abstract
PURPOSE: The incidence and prognosis of Pacific Islanders with gastric cancer is not well documented as previous studies have often aggregated this population with Asians. The purpose of our study was to describe patient and tumor characteristics, as well as prognostic factors of Pacific Islanders with gastric cancer. METHODS: Patients diagnosed with gastroesophageal junction or gastric adenocarcinoma between 2000 and 2014 were identified in the tumor registry of the largest hospital in Hawaii. Overall survival of Asians, Whites, and Pacific Islanders were calculated using the Kaplan-Meier method and log-rank test. Cox proportional hazards regression models were constructed to assess predictors of survival adjusting for clinical and pathological factors. RESULTS: A total of 615 patients were included in the final analysis. Pacific Islanders were found to present at a younger age, were more often uninsured or had Medicaid insurance, and were diagnosed with a higher stage of cancer compared to their Asian and White counterparts. Pacific Islanders were less likely to undergo surgery even after adjusting for stage. Race was a prognostic factor and survival was lowest among Pacific Islanders, but only if the model was unadjusted for treatment. CONCLUSIONS: We present an analysis of the largest cohort of Pacific Islander gastric cancer patients. Pacific Islanders have different sociodemographic characteristics and inferior survival compared to Asian patients and should be independently studied.
PURPOSE: The incidence and prognosis of Pacific Islanders with gastric cancer is not well documented as previous studies have often aggregated this population with Asians. The purpose of our study was to describe patient and tumor characteristics, as well as prognostic factors of Pacific Islanders with gastric cancer. METHODS: Patients diagnosed with gastroesophageal junction or gastric adenocarcinoma between 2000 and 2014 were identified in the tumor registry of the largest hospital in Hawaii. Overall survival of Asians, Whites, and Pacific Islanders were calculated using the Kaplan-Meier method and log-rank test. Cox proportional hazards regression models were constructed to assess predictors of survival adjusting for clinical and pathological factors. RESULTS: A total of 615 patients were included in the final analysis. Pacific Islanders were found to present at a younger age, were more often uninsured or had Medicaid insurance, and were diagnosed with a higher stage of cancer compared to their Asian and White counterparts. Pacific Islanders were less likely to undergo surgery even after adjusting for stage. Race was a prognostic factor and survival was lowest among Pacific Islanders, but only if the model was unadjusted for treatment. CONCLUSIONS: We present an analysis of the largest cohort of Pacific Islander gastric cancer patients. Pacific Islanders have different sociodemographic characteristics and inferior survival compared to Asian patients and should be independently studied.
Authors: Yufei Chen; Jan Willem Haveman; Christos Apostolou; David K Chang; Neil D Merrett Journal: Gastric Cancer Date: 2014-05-25 Impact factor: 7.370
Authors: J Kim; C-L Sun; B Mailey; C Prendergast; A Artinyan; S Bhatia; A Pigazzi; J D I Ellenhorn Journal: Ann Oncol Date: 2009-07-21 Impact factor: 32.976
Authors: Lihua Liu; Anne-Michelle Noone; Scarlett Lin Gomez; Steve Scoppa; James T Gibson; Daphne Lichtensztajn; Kari Fish; Lynne R Wilkens; Marc T Goodman; Cyllene Morris; Sandy Kwong; Dennis Deapen; Barry A Miller Journal: J Natl Cancer Inst Date: 2013-07-22 Impact factor: 13.506
Authors: Andrew McKay; Jeniva Donaleshen; Ramzi M Helewa; Jason Park; Debrah Wirtzfeld; David Hochman; Harminder Singh; Donna Turner Journal: World J Surg Oncol Date: 2014-12-02 Impact factor: 2.754